Brewer et al, 2016,60 United States |
Obstetricians |
85.4% said that NIPT was a screening test for fetal aneuploidy; 14.6% said that it was a diagnostic test
40.8% said they would recommend diagnostic testing for fetal aneuploidy for all 23 chromosomes; 46.6% said they would recommend NIPT
92.2% agreed that the sensitivity of NIPT is better than traditional prenatal screening for trisomy 21
81.5% agreed that NIPT performs well, regardless of age or risk, and should be offered as a screening option for any pregnant person, regardless of age or risk status
|
Filoche et al, 2017,61 New Zealand |
Obstetricians |
35.2% felt “very confident” in offering NIPT for fetal aneuploidy; 40.6% felt “quite confident”
30.7% felt “very confident” in explaining positive predictive value
23.6% felt “very confident” in explaining fetal fraction
|
Haymon et al, 2014,{Haymon, 2014 #947} United States |
Maternal–fetal medicine specialists |
|
Mayes et al, 2016,63 United States |
Obstetricians |
75% were aware of expanded NIPT options (testing for additional trisomies and microdeletion syndromes)
50% told patients that the accuracy of the expanded testing option is 99% to 100%; 25% said 90% to 98%
34% who did not order expanded NIPT would feel at least somewhat comfortable explaining the testing to patients; 83% of those who did order expanded NIPT would feel at least somewhat comfortable
14% who did not order expanded NIPT identified it as a diagnostic test; 33% who did order expanded NIPT identified it as a diagnostic test
41% who felt comfortable explaining expanded NIPT agreed that its clinical utility and validity has been established; only 7% who were not comfortable explaining expanded NIPT agreed that its clinical utility and validity has been established
|
Musci et al, 2013,64 United States |
Obstetricians |
32% already included NIPT in their practice; 22% were familiar with the published literature but had not yet ordered tests
39% had heard of the technology, but were less familiar with the data; 8% had never heard of NIPT
|
Sayres et al, 2011,65 United States |
Mainly obstetricians but also nurses and nurse–midwives |
|
Swaney et al, 2016,66 United States |
Maternal–fetal medicine fellows |
97.4% agreed that NIPT is screening test, not a diagnostic test
42.1% knew that the test was available for twins but could not identify which twin was carrying the aneuploidy; 48.2% were unaware of the possible use of NIPT in twins
81.9% knew that NIPT could be offered after 10 weeks’ gestation; 13.8% thought it could be offered at any time
63% were comfortable ordering NIPT without further education; 23% would not independently order the test based on their current knowledge level
|